Interleukin-2 (IL-2)-activated lymphocytes interact directly with, and inhibit, the growth of Candida albicans hyphae. C. albicans-stimulated natural killer (NKl.l+) lymphocytes were demonstrated to secrete a soluble product capable of directly affecting C. albicans yeast forms. Antibodies specific for interferon-y completely eliminated the antifungal activity of the NK1.1+ lymphocyte product and diminished the antifungal activity of NK1.1+ lymphocytes against C. albicans. Antibodies specific for other cytokines had no such effect. These data demonstrate that C. albicans-stimulated NK1.lS lymphocytes have antifungal activity against C. albicans yeast cells via the release of interferon-y. This antifungal activity was demonstrable with no effect on C. albicans hyphae.
Introduction
Natural killer (NK) cells have been shown to inhibit the growth of several fungi, including Cryptococcus neoformans, Paracoccidioides brasiliensis, Coccidioides immitis and Histoplasma capsulatum [ 11. NK cells have no apparent capacity to inhibit the growth of Candida albicans [2-41. NK cell-mediated inhibition of growth of fungi, other than C. albicans, is absolutely dependent on the direct contact of NK cells with the fungal surface. Even though NK cells do not inhibit the growth of C. albicans, NK cells as well as large granular lymphocytes (LGL), have been shown to interact with the surface of both C. albicans yeast cells and hyphae [3-61. This interaction has been demonstrated by competitive inhibition of lymphocyte binding to C. albicans [3, 4] , by direct measurement of adhesion of lymphocytes to fungal hyphae [2, 6] and by yeast cell stimulation of cytokine synthesis in LGL ~7 1 .
NK cells and other lymphocyte populations can be activated by extended culture with interleukin-2 (IL-2) [8-lo] . When C57B1/6 mouse lymphocytes are activated with IL-2, two lymphocyte populations are produced; a CD8+ NK 1.1-pan-cytotoxic T lympho-only against the yeast form of the fungus, cyte population and a CD8-NK 1.1+ activated NK cell population [9-111. Both IL-2-activated CD8+ lymphocytes as well as IL-2-activated NK1. I+ lymphocytes bind C. albicans [9] . IL-2 activation produces lymphocytes with antifungal activity against the hyphal form of the fungus [3, 81. The antifimgal activity is produced by lymphocytes that express CD8 but do not express NK1.l [9] . This CD8+ lymphocyte population not only affects the growth of C. albicans hyphae but is also cytotoxic for multiple tumour cell lines with distinct major histocompatibility complex (MHC) antigens. The functional activity of the lymphocyte population is consistent with that of lymphokine-activated killer (LAK) cells [9] . Under similar test conditions, IL-2-activated NKl . If lymphocytes had no antifungal activity against C. albicans hyphae.
This investigation aimed to determine whether IL-2-activated NK1.1 + lymphocytes were capable of exerting an antifungal activity against C. albicans yeast cells. In the C57B1/6 mouse, NKl.l is a marker for both NK cells and cytokine-actiyated NK cells. NK cells, LGL and LAK cells can be induced to produce various cytokines, including interferon-y (IFN-y), IL-2, tumour necrosis factor (TNF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) [12-141. C. aZbicans yeast cells have been shown to induce the release of TNF [7] and GM-CSF [5] directly from such cells without the necessity for a priming signal.
Materials and methods
Stimulation of IL-2-activated lymphocytes with C. albicans Mice C57B 1 /6 female mice, aged 6-7 weeks, were obtained from Jackson Laboratory, Bar Harbor, ME, USA. Mice were 6-12 weeks of age when used in experiments.
Fungal cultures
C. albicans ATCC 58716 was obtained from Dr T. Hashimoto, Loyola University Medical Center, Maywood, IL, USA, and used throughout this investigation. The cultures were stored at 25°C on Sabouraud's Dextrose Agar (SDA) (Becton Dickinson., Cockeysville, MD, USA). The cells were cultured overnight at 37°C on SDA, collected as isolated colonies and washed once in Hanks's Balanced Salts Solution (HBSS). C. albicans hyphal forms were obtained by incubation at 37°C in RPMI 1640. Clinical isolates of C. albicans were obtained from the Clinical Laboratories, Loyola University Medical Center.
Recombinant molecules, antibodies and the detection of IFN-y
Recombinant human IL-2 was obtained from Hoffmann LaRoche, Nutley, NJ, USA. Recombinant mouse IFNy , recombinant mouse TNF and recombinant mouse GM-CSF were obtained from Genzyme, Cambridge, MA, USA. The effects of IFN-y were tested as described in the text. The effects of the other cytokines were evaluated with maximal assessment of IL-2 at 1500 units/assay, TNF at 1500 units/assay and GM-CSF at 100 units/assay. Murine IFN-y was detected with ELISA kits obtained from Genzyme. Monoclonal hamster anti-mouse IFN-y, monoclonal hamster antimouse TNF and monoclonal rat anti-mouse GM-CSF antibodies (MAbs) were obtained from Genzyme and assessed for effects at concentrations of up to 0.5 ,ug/assay. These MAbs were all IgG.
IL-2 activation of splenocytes
Spleens from untreated mice were removed aseptically. Single cell suspensions were prepared by dissociating the spleen through a 60-gauge wire mesh with the hub of a syringe. Spleen cells were washed once in HBSS and dispensed in culture medium containing 5 X 1 0-5 M 2-mercaptoethanol (2-ME) at a concentration of 2.5 X lo6 cells/ml with IL-2 1500 U/ml in Falcon Multiwell plates (Becton Dickinson). This quantity of IL-2 has been shown previously to be optimal for the induction of antifungal activity in IL-2-activated lymphocytes [ 81. Non-adherent cells were harvested after incubation at 37"C, overlaid on to Lymphocyte Separation Medium (Litton Bionetics, Kensington, MD, USA) and centrifuged at 1000 g for 20 min. The cells at the interface were washed twice with HBSS before assessment of growth inhibitory activity. These splenocytes were > 99% lymphocytes, as judged by Wright-Giemsa staining.
IL-2-activated lymphocytes were prepared as described above and 1 X lo6 cells were placed into Falcon multiwell plates containing 1 ml of RPMI 1640 and either 1 X lo5 C. albicans yeast or the hyphal forms prepared from 1 X lo5 C. albicans yeasts as described above. After stimulation with C. albicans for 1-4 h at 37°C in air with CO2 5%, the supernates of the cocultures of lymphocytes with C. albicans were collected, centrifuged at 1000 g, filtered through a 0.45-pm filter (Gelman Sciences, ,4nn Arbor, MI, USA) and immediately assayed for effects on C. albicans. These conditions were found to be optimal for the production of antifungal supernates. Larger numbers of C. albicans or longer periods of incubation did not increase the antifungal activity of the culture supernates.
Complement-mediated depletion analysis
Antibodies used to deplete cell populations were MAb anti-CD8 (clone AD4; mouse IgM) from Accurate Chemical and Scientific Corp. (Westbury, NY, USA) and MAb anti-NK 1.1 (clone PK136; mouse IgG) obtained from the American Type Culture Collection (ATCC; Rockville, MD, USA). Viable lymphoid cells were obtained with lymphocyte separation medium as above and washed twice with HBSS. Lymphocyte populations were depleted of those cells bearing specific antibodies by incubating 1 : < lo7 cells with saturating levels of antibody for 1 h at 4°C. The cells were washed three times with HBSS to remove excess antibody and then 100 pl of Low Tox M rabbit complement (Accurate Chemical and Scientific Corp.) were added to the cell pellet. After incubation for 1 h at 37"C, cells were washed once with HBSS, separated by use of lymphocyte separation medium as above and washed twice with HBSS before assessment of their growth inhibitory activity. The effectiveness of the depletion was assessed by direct imniunofluorescence and the number of cells recovered from treated populations was compared with that from untreated populations. IL-2-activated lymphocytes depleted by treatment with anti-CD8 and complement showed background levels (5.3 SD 3.3) of CD8+ cells as judged by direct microscopic immunofluorescence.
Anti-NK1 . 1 -and complement-treated IL-2-activated lymphocytes showed background levels (4.6 SD 4.1) of NKl.lf cells as judged by direct microscopic immunofluorescence. Cells were re-counted after complement depletion and resuspended to the indicated cell concentration before measurement of antifungal activity.
Inhibition growth of C. albicans
The antifungal activity of lymphocytes for C. albicans was determined as described previously [ 1 11. Briefly, fungal cells used for experimentation were collected from isolated, overnight SDA colonies and washed once in HBSS. Yeasts were resuspended to 2 X 105/ml in RPMI 1640 and 1 X lo4 yeasts were added to individual wells of 96-well, flat-bottomed plates (Corning 25861, Corning, NY, USA). C. albicans hyphal forms were obtained by incubation at 37°C in air with C02 5% for 2 h. Lymphocytes were added to give varying effector to target ratios. After incubation for 2 h at 37°C in air with C02 5%, effector lymphocytes were lysed and removed by washing with water in a PHD cell harvester (Cambridge Technology, Cambridge, MA, USA). Then 0.05 ml of RPMI 1640 containing 1 pCi of [3H] uridine (ICN Radiochemicals, Irvine, CA, USA) was added to individual wells. After incubation for 1 h at 37"C, in air with C02 5%, the [3H] uridine was removed by washing and 25 U of lyticase (Sigma) in 50 pl of HBSS was added to individual wells for 0.5 h at 25°C. Cells were then harvested with a PHD cell harvester and incorporated radioactivity was determined with a Beckman LS5801 p liquid scintillation counter. Growth inhibition of C. albicans = {(DPM C. albicans control) -DPM (effector and C. albicans -effector control)/DPM C. albicans control) X 100. All cultures were prepared at least in triplicate and the mean inhibition values were determined. The effects of lymphocytes on the yeast form of C. albicans were determined as described above except that lymphocytes were added to assay wells containing C. albicans yeast cells. C. albicans yeasts cells were placed in flat-bottomed plates in HBSS 15 min before the addition of lymphocytes to facilitate the association of the yeasts with the plastic surface of the assay wells. After 2 h, the lymphocytes were removed. All further procedures were as described above for hyphae. Yeast germination was scored microscopically.
Statistical analysis
The results are expressed as means and SD. The data were analysed by one-way ANOVA and further analysed by Student Newman-Kvels test for multiple comparisons between groups; p <0.05 was considered significant.
Results

Effect of C. albicans-stimulated culture supernates on the growth of C. albicans yeast and hyphae
A previous study showed that conditioned media from IL-2-activated lymphocytes (unstimulated culture supernates) had no antifungal effect against the hyphal form of C. albicans [3] . This study assessed whether culture supernate of C. albicans-stimulated IL-2-activated lymphocytes could affect the fungus. Lymphocytes cultured for 7 days with IL-2 were stimulated with either the yeast or hyphal forms of C. albicans. These stimulated culture supernates were then assessed for their capacity to inhibit the growth of the hyphal form of C. albicans (Fig. 1) Microscopic observation of C. albicans treated with culture supernates, from co-culture of IL-2-activated lymphocytes with C. albicans, showed these to be retarded in their capacity to germinate (Fig. 2) . The retardation in germination of these yeasts was apparent from 30 to 90 min after the addition of the stimulated culture supernate. By 120 min all had germinated. In contrast, no effect on germination was observed when yeasts were treated with supernates from co-culture of IL-2-activated lymphocytes with C. albicans hyphae. Media conditioned by either yeast or hyphae (without mammalian cells) had no effect on yeast germination. Media conditioned by IL-2-activated lymphocytes (without either yeasts or hyphae) had no effect upon germination.
Cytokine effects on the germination of C. albicans yeasts C. albicans has been shown previously to induce lymphocytes to release TNF and GM-CSF [5, 7] . Those cytokines and IFN-y were evaluated for their capacity to inhibit yeast germ-tube formation (Fig. 3) . IFN-y directly inhibited germination. Antibodies reactive with IFN-y (0.1 pglculture well) abolished the effect of the cytokine, whereas antibodies reactive with either TNF or GM-CSF had no effect on IFN-y inhibition of yeast germ-tube formation at concentrations as high as 0.5 p u g of antibody/yeast culture (data not shown). TNF and IL-2 (1 500 units/yeast culture) and GM-CSF (100 units/yeast culture) had no effect upon germ-tube formation when added directly to yeasts.
Effect of anti-IFN-y on the antifungal activity of IL-2-activated lymphocytes
Extended culture of C57B 1 / 6 splenocytes with high dose IL-2 produced two LGL populations, one which was CD8+ and another which was NKl.l+ [lo] . These cell populations were enriched by use of specific antibodies and complement and their capacity to inhibit the growth of C. albicans yeast cells was determined (Fig. 4) . Both CD8+ atid NK1.lf cell populations had the capacity to inhibit the growth of C. the NK1.1+ cell population significantly (p < 0.05) reduced the antifungal effect of the lymphocytes at effector: target ratios of 50: 1 and 25: 1. In contrast, the CSF were added to either cell population (data not shown).
addition of anti-IFN-y to the CD8+ cell population had no effect on the capacity of the lymphocytes to inhibit
IFN-y production by IL-2-activated lymphocytes
the growth of the yeast form of the fungus. No effect was observed when antibodies to either TNF or GM-CD8+ and NKl.l+ cell populations were prepared by antibody and complement depletion and assessed for their capacity to produce IFN-y when stimulated with C. albicans yeast cells. As shown in Fig. 5 , the NK1.1+ cell population released IFN-y when stimulated with C. albicans but the CD8+ cell population did not. When the CD8' cell population was assayed by ELISA for cell-associated IFN-y , none was detected (data not shown).
Discussion
To date, investigations in this laboratory have focused on the effects of IL-2-activated lymphocytes upon the hyphae of C. albicans. They have shown that extended culture of mouse lymph node cells, mouse splenocytes or human peripheral blood mononuclear cells with high concentrations of IL-2 results in a population of lymphocytes capable of inhibiting the growth of C. because it has been demonstrated to be the most resistant to challenge with C. albiciins [15] . In this murine system, studies have shown that IL-2-activated CD8+ lymphocytes mediate an antifungal effect against hyphae but NKl.l+ lymphocytes do not [9] . Even cytokine-activated NK1.lf lymphocytes had no effect against hyphae. This is consistent with recent observations with human IL-2-activated NK cells that failed to demonstrate an antifungal effect against C. albicans [2]. Those IL-2-activated lymphocytes were MHC unrestricted in their cytotoxic activitjr for tumour cell lines, but the cell population contained only 1.5% T cells. The inability of that cell populalion to inhibit the growth of C. albicans hyphae in vitro is most probably due to absence of CD8+ T lymphocytes [9] . This IL-2-activated cell population was produced with culture conditions different from the methods employed in the present study and in our previous investigations [3, 8, 9] . The difference in culture conditions may directly relate to the observed differences in antifungal effect upon C. albicans hyphae. An absolute requirement for the generation of antifungal effector lymphocytes is the extended culture period with high dose IL-2 [3, 8, 91. It is clear that all LAK cells do not mediate an antifungal effect, particularly if they are activated NK cells [2] . The production of an antifungal effect against C. albicans hyphae requires IL-2-activated CD8+ lymphocytes in the murine system.
The assay used to measure antifungal effects against C. albicans in the present study is one which has been shown to be sensitive, rapid and reproducible [Ill. It compares well with other assays of antifungal activity and in this laboratory is the most sensitive and reproducible of the described assays. This may be important with regard to the capacity of IL-2-activated NK1.1+ lymphocytes to inhibit the yeast-to-hyphal transition by the production of INF-y. The effect of IFN-y upon the yeast-to-hyphal transition is only a retardation in the ability of the yeast to enter a germtube stage. This effect of IFN-y was maximal during the first 90 min with all yeast cells germinated by 120 min. The use of radioactive precursor incorporation assays that extend for signifcantly longer periods of time would not necessarily detect this effect on the growth of the micro-organism. It is well known that the C57B1/6 mouse strain produces high levels of IL-2 and IFN-y when challenged with C. albicans [20] . 
